The research team carried out team-building activities in 2025 focusing on “alleviating scientific research pressure and stimulating innovative thinking”
In 2024, Song Huaxin obtained the project supported by NSFC for Young Scientists
The clinical research standards for P53 restorer proposed by the research group in 2025 were published in Nat Rev Cancer
